Open Surgical Conversion After Failed Endovascular Aneurysm Sealing

Sven R Mathisen,1 Simen Tveten Berge1,2 1Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway; 2Department of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayCorrespondence: Sven R Mathisen, Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway, Tel +47-916 38 282, Email [email protected] Simen Tveten Berge, Department of Vascular Surgery, Department of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Tel +47-977 23 220, Email [email protected]: The aim of this study was to investigate the early and late outcomes of Open Surgical Conversion (OSC) following the failure of Endovascular Aneurysm Sealing (EVAS) endografts, regarding surgical technique, morbidity and mortality.Method and Material: A single center retrospective observational cohort of 46 patients undergoing OSC after EVAS failure. Primary endpoints were primary technical procedural success and 30-day mortality. Secondary endpoints were complications and primary prosthesis patency.Results: Primary technical procedural success was 97.8% (45/46). Elective 30-day mortality for OSC was 10.9% (5/42) and 75% (3/4) for acute OSC procedures. Median survival after OSC was 4.2 years (IQR 1.0, 4.9 years). Four peri-operative and 17 post-operative complications were registered. Major complications included bleeding, myocardial infraction, acute renal failure and splenectomy. Primary prosthesis patency was 82.6% (38/46) at 30-days. At median follow-up of 4.7 years (IQR 3.9, 5.3 years) 69.6% (32/46) of the patients are still alive with patent vascular prostheses.Conclusion: Open surgical conversion achieved acceptable technical success rate for failed EVAS, with better outcomes in elective versus emergency procedures. Enhanced surveillance with timely interventions before rupture and careful patient selection through multidisciplinary evaluation are essential for optimizing surgical outcomes.Keywords: EVAS failure, open surgical conversion, EVAS, endoleak, secondary intervention, secondary AAA rupture

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-06-01
Primary Topic
Magnetic confinement fusion research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Open Surgical Conversion After Failed Endovascular Aneurysm Sealing

SHILAP Revista de lepidopterología
Magnetic confinement fusion research
article

Open Surgical Conversion After Failed Endovascular Aneurysm Sealing

article en

Abstract

Sven R Mathisen,1 Simen Tveten Berge1,2 1Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway; 2Department of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayCorrespondence: Sven R Mathisen, Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway, Tel +47-916 38 282, Email [email protected] Simen Tveten Berge, Department of Vascular Surgery, Department of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Tel +47-977 23 220, Email [email protected]: The aim of this study was to investigate the early and late outcomes of Open Surgical Conversion (OSC) following the failure of Endovascular Aneurysm Sealing (EVAS) endografts, regarding surgical technique, morbidity and mortality.Method and Material: A single center retrospective observational cohort of 46 patients undergoing OSC after EVAS failure. Primary endpoints were primary technical procedural success and 30-day mortality. Secondary endpoints were complications and primary prosthesis patency.Results: Primary technical procedural success was 97.8% (45/46). Elective 30-day mortality for OSC was 10.9% (5/42) and 75% (3/4) for acute OSC procedures. Median survival after OSC was 4.2 years (IQR 1.0, 4.9 years). Four peri-operative and 17 post-operative complications were registered. Major complications included bleeding, myocardial infraction, acute renal failure and splenectomy. Primary prosthesis patency was 82.6% (38/46) at 30-days. At median follow-up of 4.7 years (IQR 3.9, 5.3 years) 69.6% (32/46) of the patients are still alive with patent vascular prostheses.Conclusion: Open surgical conversion achieved acceptable technical success rate for failed EVAS, with better outcomes in elective versus emergency procedures. Enhanced surveillance with timely interventions before rupture and careful patient selection through multidisciplinary evaluation are essential for optimizing surgical outcomes.Keywords: EVAS failure, open surgical conversion, EVAS, endoleak, secondary intervention, secondary AAA rupture

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 45%
Magnetic confinement fusion research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.